在阿尔茨海默病中使用MIND网络绘制结构断开和转录基因特征的地图
Yongsheng Wu1, Hao Zhang2, Junyu Qu1
1Qilu Hospital of Shandong University, Department of Radiology, Jinan, Shandong, 250012, China.
Brain research bulletin
|January 18, 2026
概括
阿尔茨海默病 (AD) 涉及到大脑网络的断开. 新的MIND方法绘制了这些结构变化及其遗传联系的地图,在诊断AD方面表现优于以前的方法.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 阿尔茨海默病 (AD) 越来越多地被视为影响大脑网络的断开综合征.
- 顶部层面的结构断裂及其在AD中的分子基础尚未得到充分理解.
- 形态测量反向分歧 (MIND) 提供了一种新的方法,用于详细地绘制AD中的结构断裂及其转录组相关物.
研究的目的:
- 使用MIND方法绘制阿尔茨海默病中的结构性断开模式.
- 研究MIND变化,认知表现和AD生物标志物之间的关联.
- 探索AD中MIND连接组变化的转录基因.
- 评估与形态相似性网络 (MSN) 相比,MIND的诊断性能.
主要方法:
- 应用MIND对两个独立的数据集 (ADNI和Qilu),包括AD和认知正常 (CN) 个体.
- 与认知分数 (MMSE) 和生物标志物数据 (CSF Aβ-42,FDG-PET SUVR) 相关联的MIND网络变化.
- 使用部分最小平方回归和基因丰富分析将MIND连接组与空间基因表达数据联系起来.
- 开发了一个深度神经网络 (ResDNN) 来比较MIND与MSN的诊断性能.
主要成果:
- 额叶,叶和叶观察到的MIND程度下降与认知功能和代谢活动有积极的相关性.
- 在中间叶区域发现的MIND程度增加与认知和AD生物标志物有负相关性.
- 心智变化与与突触功能,神经传递和新陈代谢相关的基因表达特征有关.
- 与MSN相比,MIND在区分AD和CN方面表现出更高的诊断准确性 (AUC=0.90/0.88).
结论:
- 这种MIND方法有效地绘制出阿尔茨海默病中的结构性断开模式.
- 这些模式与特定的转录基因特征相关,增强了对AD作为脱节综合征的理解.
- 作为一个机械学和AD临床研究的敏感工具,MIND显示出显著的希望.
更多相关视频
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
09:47DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
Published on: December 15, 2023
相关概念视频
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
